Indonesia banned ingredients linked to the deaths of 70 children in Gambia from cough syrups as the Southeast Asian country investigates acute kidney damage that has killed more than 20 children in the capital Jakarta this year.
Food and drug regulator BPOM also said it was investigating the possibility that the ingredients, diethylene glycol and ethylene glycol, had contaminated other materials used as solvents.
Gambia and India are investigating the deaths from acute kidney injury in the west-African country thought to be linked to cough syrups made by New Delhi-based Maiden Pharmaceuticals Ltd.
The World Health Organization has said it found "unacceptable" levels of the ingredients, which can be toxic, in four Maiden products.
"To protect the public, BPOM has set a requirement at the time of registration that all medicinal syrup products for children and adults are not allowed to use diethylene glycol (DEG) and ethylene glycol (EG)," the regulator said in a statement.
The BPOM reiterated that the four products linked to the deaths in Gambia are not registered in Indonesia, nor are any other Maiden products.
Toll from Russia's deadliest airstrike on Ukraine in weeks rises to 18
UNRWA chief warns man-made famine tightening grip across Gaza
Indonesian volcano eruption forces evacuations, airport closure
US House to vote on Ukraine and Israel aid, despite hardline objections
Georgia proceeds with 'foreign agents' bill amid EU concerns
